FDA Investigator Tara G Bizjak

Tara G Bizjak has inspections in 5 countries as of 21 Sep 2023. Tara G Bizjak has collaborated with a combinined 4114 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

21 Sep 2023

Investigator Role:

FDA Investigator

Redica ID:

100009490

Country:

India, United States of America, United Kingdom of Great Britain and Northern Ireland, Netherlands, Malta

Co-Investigator(s):

Abdollah Koolivand, Addam S Reynolds, Ademola O Daramola, Adetutu M Gidado, Albert M Brindle, Alberto A Viciedo, Allen Lou, Amatul H Marium, Amy L Singer, Amy M Codella, Amy M Cramer, Amy W Yan Mai, Ana S Cabrera, Ankur C Patel, Annemarie B Randow, Annemarie Bodnar, Anthony A Charity, Anthony J Donato, Anthony M Criscuolo, Jr, Anthony N Onianwa, Arsen Karapetyan, Ashutosh Rao, PhD, Atul J Agrawal, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Bonita S Chester, Burnell M Henry, Byungja E Marciante, Cary Greene, Charles J Chacko, Christina N Maurino, Christopher S Keating, Cory Greene, Craig D Zagata, Craig W Swanson, Cynthia Jim, CSO, Daniel J Grabicki, Daniel J Roberts, Dawn C Olenjack, Dawn L Wydner, Deborah B Nixon, Dennis Cantellops Paite, Dennis E Guilfoyle, PhD, Dhaval H Patel, Diane M Gubernot, Dipesh K Shah, Donald C Obenhuber, PhD, Donald L Lech, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Sriram Subramaniam, PhD, Elena Karnaukhova, PhD, Emest F Bizjak, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric Rothschild, Erin D Mccaffery, Farhana Khan, Ferderick Razzaghi, Frank J Marciniak, Frank W Perrella, Frederick Razzaghi, George M Ibrahim, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Guo Q Shen, Hanisol Fabenelle, Helen B Ricalde, Helen Verdel, Ivis Lnegron Torres, James C Maclaughlin, James D Planchon, Javier E Santos, Jawaid Hamid, Jay B Shah, Jean M Kelahan, Jeffery B Medwid, PhD, Jeffrey J Ebersole, Jennifer Macmillan, Jessica S Estriplet, Jogy George, Jonee J Mearns, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose M Cayuela, Joseph F Mcginnis, RPh, Joy R Kelna, Joy Rkozlowski Klena, Julie D Bringger, Junho Pak, Justine Tomasso, Karen D'crazio, Karen E D'orazio, Karishma G Gopaul, Karishma Gopaul, Keith M Reilley, Keith M Reilly, Kelli F Dobilas, Kelli F Regenye, Kelli F Regenyl, Kelly Doremus, Kelly I Anderson, Kevin Obrien, Kham Phommachanh, Kimberley A Hoefen, King, Kinh Q Mac, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Lakecha N Lewis, Lata C Mathew, PhD, Lauren L Vajo, Laurie B Frazier, Lawrence R Johnson, Li Li, Liatte Kreuger, PharmD, Libia M Lugo, Lisa B Hall, Lisa Harlan, Lisa L Flores, Luis M Burgos Medero, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Sands, Margaret Sand, Maria Estrella, Maridalia Torres Irizarry, Marisol Faberlle, Marjorie D Schultz, Marvin D Jones, Massoud Motamed, Matthew A Spataro, Matthew Sparato, Melba Trivera Clavell, Melissa A Freeman, Melissa B Libby, Melissa J Garcia, Melissa T Roy, Meredith L Sheridan, Merril E Racke, Meyer J Slobotsky, Michael R Klapal, Michael Serrano, Michele Gottshall, Michele L Obert, Monika Borkowska, Morea K Harmen, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nerizza B Guerin, Nicholas A Violand, Nicholas L Paulin, Nicole K Trudel, Niketa Patel, Nikki S Ramirez, Omotunde O Osunsanmi, Parul M Patel, Patrick L Wisor, Paul L Bellamy, Peter R Lenahan, Pratik S Upadhyay, DDC, Rafeeq A Habeeb, Ramon A Hernandez, Rebecca E Dombrowski, Rebecca Parrilla, Regina T Brown, Remache, Reyes Candau Chacon, PhD, Richard D Manney, Richard H Penta, Richard Heath Coats, Robert G Ruff, Robert J Maffei, Robert Sharpnack, Robin P Mathew, Rochelle K Kimmel, Rochelle L Campbell, Rochelle L Cross, Roger J Adams, Russell J Glapion, Saleem A Akhtar, Sandra A Boyd, Sandra A Hughes, Sarah Adella Fave, Sarah Forney, Satheesh Thomas, Schultz, Sean G Casey, Sherri J Liu, Shirshendu K Deb, PhD, Sinai Davis, State Agency, Stephanie T Durso, Stephen J Mottola, Stephenie M Ortiz, Steven C Madzo, Steven M Weinman, Susan M Halsted, Susanna E Ford, Analyst, Tania E Garcia, Tania E Vizcaino, Tara R Bizjak, Tara R Gooen, Temar Q Williams, Terri L Dodds, Tiffani D Wilson, Tomika L Bivens, Tonia F Bernard, Tracey L Harris, Tressa T Lewis, Tricia S Martinez, Unnee Ranjan, Valerie C Reed, Valerie Reed, Victoria Spivak, Wayne J Meyer, Wayne T Smith, William J Leonard, Xikui Chen (nmi), PhD, Yoriann Mcabrera Bartolomei, Youmin Wang, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu

Tara G Bizjak's Documents

Publish Date	Document Type	Title
October, 2003	FDA 483	Packaging Systems, LLC - Form 483, 2003-10-15
April, 2006	FDA 483	Leading Pharma, LLC - Form 483, 2006-04-18
November, 2003	EIR	Ivax Pharmaceuticals Inc - EIR, 2003-11-17
July, 2003	EIR	Vantage Specialty Ingredients, Inc - EIR, 2003-07-30
October, 2006	FDA 483	Ameriderm Laboratories, Ltd. - Form 483, 2006-10-31
April, 2003	FDA 483	Penick Corp - Form 483, 2003-04-03
August, 2003	FDA 483 Response	ACUPAC PACKAGING INC - Form 483R, 2003-09-03
June, 2003	EIR	Unigene Laboratories, Inc. - EIR, 2003-06-16
June, 2006	FDA 483	N.V. Organon - Form 483, 2006-06-28
November, 2003	FDA 483	Ivax Pharmaceuticals Inc - Form 483, 2003-11-19
November, 2005	EIR	Amneal Pharmaceuticals, LLC - EIR, 2005-11-25
July, 2003	FDA 483	Hudson Cosmetics Manufacturing Corp. DBA Paramount Cosmetics - Form 483, 2003-07-10
December, 2003	FDA 483 Response	Consumer Product Testing Company, Inc - Form 483R, 2004-01-09
April, 2003	EIR	Compass Pharma Services, LLC - EIR, 2003-04-10
March, 2003	EIR	Able Laboratories Inc. - EIR, 2003-03-14
August, 2003	EIR	ACUPAC PACKAGING INC - EIR, 2003-08-11
February, 2006	EIR	Actavis Totowa LLC - EIR, 2006-02-08
August, 2003	FDA 483	ACUPAC PACKAGING INC - Form 483, 2003-08-11
June, 2005	EIR	Amneal Pharmaceuticals, LLC - EIR, 2005-06-07
October, 2003	EIR	Packaging Systems, LLC - EIR, 2003-10-15
December, 2003	EIR	Consumer Product Testing Company, Inc - EIR, 2003-12-18
April, 2010	FDA 483	Renaissance Lakewood LLC - Form 483, 2010-04-28
April, 2003	EIR	Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - EIR, 2003-04-24
October, 2004	EIR	Mayne Pharma (USA) Inc. - EIR, 2004-10-06
October, 2004	FDA 483	Mayne Pharma (USA) Inc. - Form 483, 2004-10-06
August, 2005	EIR	SGS North America Inc. - EIR, 2005-08-19
December, 2005	FDA 483	Merck, Inc. - Form 483, 2005-12-14
September, 2002	FDA 483	Bergen Comm Reg Blood Center - Form 483, 2002-09-20
April, 2003	EIR	Penick Corp - EIR, 2003-04-03
May, 2006	EIR	Aphena Pharma Solutions - New Jersey, LLC - EIR, 2006-05-11
June, 2003	FDA 483 Response	Unigene Laboratories, Inc. - Form 483R, 2003-06-27
June, 2005	FDA 483	Amneal Pharmaceuticals, LLC - Form 483, 2005-06-07
August, 2005	FDA 483	SGS North America Inc. - Form 483, 2005-08-19
October, 2003	FDA 483 Response	Packaging Systems, LLC - Form 483R, 2003-11-24
July, 2003	EIR	Hudson Cosmetics Manufacturing Corp. DBA Paramount Cosmetics - EIR, 2003-07-10
December, 2003	FDA 483	Consumer Product Testing Company, Inc - Form 483, 2003-12-18
March, 2006	FDA 483	Complete Analysis Laboratories Inc - Form 483, 2006-03-16
April, 2003	FDA 483	Johnson & Johnson Healthcare Products Div. Mcneil-ppc, Inc. - Form 483, 2003-04-24
August, 2005	FDA 483 Response	SGS North America Inc. - Form 483R, 2005-09-14
November, 2005	FDA 483 Response	Amneal Pharmaceuticals, LLC - Form 483R, 2005-12-19
September, 2004	EIR	Barr Laboratories Inc - EIR, 2004-09-02
April, 2010	FDA 483	Renaissance Lakewood LLC - Form 483, 2010-04-01
February, 2006	FDA 483	Actavis Totowa LLC - Form 483, 2006-02-08
March, 2003	FDA 483 Response	Able Laboratories Inc. - Form 483R, 2003-03-19
June, 2003	FDA 483	Unigene Laboratories, Inc. - Form 483, 2003-06-16
May, 2006	FDA 483	Aphena Pharma Solutions - New Jersey, LLC - Form 483, 2006-05-11
October, 2002	FDA 483	B.E.C. Manufacturing Corp. - Form 483, 2002-10-31
March, 2003	FDA 483	Able Laboratories Inc. - Form 483, 2003-03-14
July, 2003	EIR	GENERICHEM CORPORATION - EIR, 2003-07-22
November, 2005	FDA 483	Amneal Pharmaceuticals, LLC - Form 483, 2005-12-12
June, 2005	FDA 483 Response	Amneal Pharmaceuticals, LLC - Form 483R, 2005-06-16
April, 2003	FDA 483 Response	Penick Corp - Form 483R, 2003-04-10
June, 2006	EIR	N.V. Organon - EIR, 2006-06-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more